A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections

Namei Wu(University of Science and Technology of China), Yucai Wang(University of Science and Technology of China)
Molecular Therapy
February 9, 2024
Cited by 20


Related Papers